Variant alleles of TGFB1 and TGFBR2 are associated with a decreased risk of gastric cancer in a Chinese population

International Journal of Cancer

Volumn 120, Issue 6, 2007, Pages 1330-1335

  Jin, Guangfu ^a   Wang, Lina ^a   Chen, Wensen ^a   Hu, Zhibin ^a   Zhou, Yan ^b   Tan, Yongfei ^b   Wang, Jianming ^c   Hua, Zhaolai ^c   Ding, Weiliang ^b   Shen, Jing ^a   Zhang, Zuofeng ^d   Wang, Xinru ^a   Xu, Yaochu ^a   Shen, Hongbing ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b YIXING PEOPLE S HOSPITAL   (China)

^c Yangzhong Cancer Research Institute   (China)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Gastric cancer; Molecular epidemiology; Polymorphisms; TGFB1; TGFBR2

Indexed keywords

LEUCINE; PROLINE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ALLELISM; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CASE CONTROL STUDY; CELL DIFFERENTIATION; CELL GROWTH; CHINESE; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; STOMACH CANCER;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; FEMALE; HUMANS; LEUCINE; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROLINE; PROMOTER REGIONS (GENETICS); SEQUENCE ANALYSIS, DNA; STOMACH NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

EID: 33846989301     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22443     Document Type: Article

References (39)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Yang L. Incidence and mortality of gastric cancer in China. World J Gastroenterol 2006;12:17-20.
3. Crew KD, Neugut AI. Epidemiology of upper gastrointestinal malignancies. Semin Oncol 2004;31:450-64.
4. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-9.
5. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K. Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark and Finland. N Engl J Med 2000;343:78-85.
6. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor β in human disease. N Engl J Med 2000;342:1350-8.
7. Derynck R, Akhurst RJ, Balmain A. TGF-β signaling in tumor suppression and cancer progression. Nat Genet 2001;29:117-29.
8. Massague J, Blain SW, Lo RS. TGFβ signaling in growth control, cancer and heritable disorders. Cell 2000;103:295-309.
9. de Caestecker MP, Piek E, Roberts AB. Role of transforming growth factor-β signaling in cancer. J Natl Cancer Inst 2000;92:1388-402.
10. Markowitz SD, Roberts AB. Tumor suppressor activity of the TGF-β pathway in human cancers. Cytokine Growth Factor Rev 1996;7:93-102.
11. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B, Brattain M, Willson JK. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 1995;268:1336-8.
12. Grainger DJ, Heathcote K, Chiano M, Snieder H, Kemp PR, Metcalfe JC, Carter ND, Spector TD. Genetic control of the circulating concentration of transforming growth factor type β1. Hum Mol Genet 1999;8:93-7.
13. Kim SJ, Im YH, Markowitz SD, Bang YJ. Molecular mechanisms of inactivation of TGF-β receptors during carcinogenesis. Cytokine Growth Factor Rev 2000;11:159-68.
14. Chang J, Park K, Bang YJ, Kim WS, Kim D, Kim SJ. Expression of transforming growth factor β type II receptor reduces tumorigenicity in human gastric cancer cells. Cancer Res 1997;57:2856-9.
15. Shu XO, Gao YT, Cai Q, Pierce L, Cai H, Ruan ZX, Yang G, Jin F, Zheng W. Genetic polymorphisms in the TGF-β1 gene and breast cancer survival: a report from the Shanghai Breast Cancer Study. Cancer Res 2004;64:836-9.
16. Kim YJ, Lee HS, Im JP, Min BH, Kim HD, Jeong JB, Yoon JH, Kim CY, Kim MS, Kim JY, Jung JH, Kim LH, et al. Association of transforming growth factor-β1 gene polymorphisms with a hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection. Exp Mol Med 2003;35:196-202.
17. Migita K, Miyazoe S, Maeda Y, Daikoku M, Abiru S, Ueki T, Yano K, Nagaoka S, Matsumoto T, Nakao K, Hamasaki K, Yatsuhashi H, et al. Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection - association between TGF-β1 polymorphisms and hepatocellular carcinoma. J Hepatol 2005;42:505-10.
18. Silverman ES, Palmer LJ, Subramaniam V, Hallock A, Mathew S, Vallone J, Faffe DS, Shikanai T, Raby BA, Weiss ST, Shore SA. Transforming growth factor β1 promoter polymorphism C-509T is associated with asthma. Am J Respir Crit Care Med 2004;169:214-9.
19. Jin Q, Hemminki K, Grzybowska E, Klaes R, Soderberg M, Zientek H, Rogozinska-Szczepka J, Utracka-Hutka B, Pamula J, Pekala W, Forsti A. Polymorphisms and haplotype structures in genes for transforming growth factor β1 and its receptors in familial and unselected breast cancers. Int J Cancer 2004;112:94-9.
20. Dunning AM, Ellis PD, McBride S, Kirschenlohr HL, Healey CS, Kemp PR, Luben RN, Chang-Claude J, Mannermaa A, Kataja V, Pharoah PD, Easton DF, et al. A transforming growth factor β1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer. Cancer Res 2003;63:2610-5.
21. Le Marchand L, Haiman CA, van den Berg D, Wilkens LR, Kolonel LN, Henderson BE. T29C polymorphism in the transforming growth factor β1 gene and postmenopausal breast cancer risk: the Multiethnic Cohort Study. Cancer Epidemiol Biomarkers Prev 2004;13:412-5.
22. Hishida A, Iwata H, Hamajima N, Matsuo K, Mizutani M, Iwase T, Miura S, Emi N, Hirose K, Tajima K. Transforming growth factor B1 T29C polymorphism and breast cancer risk in Japanese women. Breast Cancer 2003;10:63-9.
23. Lee KM, Park SK, Hamajima N, Tajima K, Yoo KY, Shin A, Noh DY, Ahn SH, Hirvonen A, Kang D. Genetic polymorphisms of TGF-β1 and TNF-β and breast cancer risk. Breast Cancer Res Treat 2005;90:149-55.
24. Shin A, Shu XO, Cai Q, Gao YT, Zheng W. Genetic polymorphisms of the transforming growth factor-β1 gene and breast cancer risk: a possible dual role at different cancer stages. Cancer Epidemiol Biomarkers Prev 2005;14:1567-70.
25. Krippl P, Langsenlehner U, Renner W, Yazdani-Biuki B, Wolf G, Wascher TC, Paulweber B, Bahadori B, Samonigg H. The L10P polymorphism of the transforming growth factor-β1 gene is not associated with breast cancer risk. Cancer Lett 2003;201:181-4.
26. Kaklamani VG, Baddi L, Liu J, Rosman D, Phukan S, Bradley C, Hegarty C, McDaniel B, Rademaker A, Oddoux C, Ostrer H, Michel LS, et al. Combined genetic assessment of transforming growth factor-β signaling pathway variants may predict breast cancer risk. Cancer Res 2005;65:3454-61.
27. Ewart-Toland A, Chan JM, Yuan J, Balmain A, Ma J. A gain of function TGFB1 polymorphism may be associated with late stage prostate cancer. Cancer Epidemiol Biomarkers Prev 2004;13:759-64.
28. Li Z, Habuchi T, Tsuchiya N, Mitsumori K, Wang L, Ohyama C, Sato K, Kamoto T, Ogawa O, Kato T. Increased risk of prostate cancer and benign prostatic hyperplasia associated with transforming growth factor-β1 gene polymorphism at codon10. Carcinogenesis 2004;25:237-40.
29. Seijo ER, Song H, Lynch MA, Jennings R, Qong X, Lazaridis E, Muro-Cacho C, Weghorst CM, Munoz-Antonia T. Identification of genetic alterations in the TGFβ type II receptor gene promoter. Mutat Res 2001;483:19-26.
30. Ke X, Collins A, Ye S. PIRA PCR designer for restriction analysis of single nucleotide polymorphisms. Bioinformatics 2001;17:838-9.
31. Sparks R, Bigler J, Sibert JG, Potter JD, Yasui Y, Ulrich CM. TGFβ1 polymorphism (L10P) and risk of colorectal adenomatous and hyperplastic polyps. Int J Epidemiol 2004;33:955-61.
32. Basturk B, Yavascaoglu I, Vuruskan H, Goral G, Oktay B, Oral HB. Cytokine gene polymorphisms as potential risk and protective factors in renal cell carcinoma. Cytokine 2005;30:41-5.
33. Stanczuk GA, Tswana SA, Bergstrom S, Sibanda EN. Polymorphism in codons 10 and 25 of the transforming growth factor-β1 (TGF-β1) gene in patients with invasive squamous cell carcinoma of the uterine cervix. Eur J Immunogenet 2002;29:417-21.
34. Mazur G, Bogunia-Kubik K, Wrobel T, Kuliczkowski K, Lange A. TGF-β1 gene polymorphisms influence the course of the disease in non-Hodgkin's lymphoma patients. Cytokine 2006;33:145-9.
35. Kang HG, Chae MH, Park JM, Kim EJ, Park JH, Kam S, Cha SI, Kim CH, Park RW, Park SH, Kim YL, Kim IS, et al. Polymorphisms in TGF-β1 gene and the risk of lung cancer. Lung Cancer 2006;52:1-7.
36. Munoz-Antonia T, Li X, Reiss M, Jackson R, Antonia S. A mutation in the transforming growth factor β type II receptor gene promoter associated with loss of gene expression. Cancer Res 1996;56:4831-5.
37. Hougaard S, Norgaard P, Abrahamsen N, Moses HL, Spang-Thomsen M, Poulsen HS. Inactivation of the transforming growth factor β type II receptor in human small cell lung cancer cell lines. Br J Cancer 1999;79:1005-11.
38. Jackson RJ, Antonia SJ, Wright KL, Moon NS, Nepveu A, Munoz-Antonia T. Human cut-like repressor protein binds TGFβ type II receptor gene promoter. Arch Biochem Biophys 1999;371:290-300.
39. Plummer M, Vivas J, Fauchere JL, Del Giudice G, Pena AS, Ponzetto A, Lopez G, Miki K, Oliver W, Munoz N. Helicobacter pylori and stomach cancer: a case-control study in Venezuela. Cancer Epidemiol Biomarkers Prev 2000;9:961-5.